Cell Counting Market is estimated to be 19.7 Billion by 2029 with a CAGR of 6.6% during the forecasted period.
T
he cell counting market accounted for US$ 11.1 billion in 2020 and is estimated to be US$ 19.7 billion by 2029 and is anticipated to register a CAGR of 6.6%.
The report "Cell
Counting Market, By Product (Instruments and Consumables & Accessories),
By End-user (Research & Academic Institutes, Hospitals & Diagnostic
Labs, Biotechnology & Pharmaceutical Companies, and Others), and By Region (North America, Europe,
Asia Pacific, Latin America, and the Middle East & Africa) - Trends,
Analysis and Forecast till 2029”.
Key Highlights:
·
In 2019, DeNovix Inc. is pleased to announce that the winner
of their recent competition to receive a donation of a unique, pink Cell Drop
Automated Cell Counter is Beth Kekkonen, from the University Of Pittsburgh, USA.
Selected at random from thousands of entries from scientists worldwide, the Cell
Drop will be housed in the University’s Division of Pulmonary, Allergy, and
Critical Care Medicine.
·
HORIBA UK Ltd, Medical has introduced a new automated digital
cell morphology solution in collaboration with CellaVision to help hematology
laboratories.
Analyst View:
cell counting market primarily attributed to the
major drivers in this market such as the increased need for non-invasive
diagnosis, advancements in single cell sequencing technique, and increase in
adoption of personalized medicine. These individualized care regimes are
improving quality of life of the patients and reducing economic, societal, and
clinical burden, projecting a future of prosperity.
The applications of single cell multi-omics
primarily include oncology, cell biology, neurology, stem cell and immunology,
among others. Aside from the discovery of effective biomarkers for the
development of efficient targeted drug therapy, single cell approach also
facilitates gene expression and protein expression analyses in an individual
cell. Research and academic organizations, biotechnology and biopharmaceutical
companies, and diagnostic centers, among others, are prominent end users of
single cell multi-omics solutions.
The applications of single cell multi-omics primarily
include oncology, cell biology, neurology, stem cell, and immunology, among
others. Aside from the discovery of effective biomarkers for the development of
efficient targeted drug therapy, single cell approach also facilitates gene
expression and protein expression analyses in an individual cell. Research and
academic organizations, biotechnology and biopharmaceutical companies, and
diagnostic centers, among others, are prominent end users of single cell
multi-omics solutions.
Key Market Insights from the
report:
The cell counting market accounted for US$
11.1 billion in 2020 and is estimated to be US$ 19.7 billion by 2029 and is
anticipated to register a CAGR of 6.6%. The market report has been segmented on
the basis of product, application, and
region.
· Based on the product the global market is segmented into
instruments and consumables & accessories. The instruments segment is
further sub segmented as spectrometers, flow cytometers, hematology analyzers
and cell counters. Similarly, the consumables & accessories is segmented as
kits and reagents, accessories and others. Spectrophotometers are predicted to
hold the largest market share due to its capability to measure different
intensities of light accuracy and its applications in bioprocessing,
therapeutics, and research.
· Based on the application, the market is bifurcated into
research institutes, hospitals & diagnostic laboratories, pharmaceutical
& biotechnology companies, and others. Hospitals & Diagnostic
Laboratories are anticipated to have the highest CAGR in the forecast period.
The factors can be attributed to the rising pharmaceutical R&D expenditure
and increasing regulatory approvals for cell culture-based vaccines.
· By region, North America is anticipated to dominate the cell counting market
followed by Europe in the global scenario leads to various technological
developments in the healthcare industry and rising research activities in the
cytology with more funds available by the government. Asia Pacific market is
expected to witness significant growth rate during the forecast period owing to
the opportunities in the emerging economies and increasing R&D expenditures
for the healthcare sectors.
Before purchasing this report,
request a sample or make an inquiry by clicking the following link:
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4522
Competitive Landscape:
The prominent player operating in the global
pharmaceutical membrane filtration technologies market includes Danaher Corporation, Thermo Fisher Scientific Inc., Becton,
Dickinson and Company Merck KGaA, and Bio-Rad Laboratories.
The market provides detailed information
regarding the industrial base, productivity, strengths, manufacturers, and
recent trends which will help companies enlarge the businesses and promote
financial growth. Furthermore, the report exhibits dynamic factors including
segments, sub-segments, regional marketplaces, competition, dominant key
players, and market forecasts. In addition, the market includes recent
collaborations, mergers, acquisitions, and partnerships along with regulatory
frameworks across different regions impacting the market trajectory. Recent
technological advances and innovations influencing the global market are
included in the report.
About Prophecy Market Insights
Prophecy Market Insights is specialized market
research, analytics, marketing/business strategy, and solutions that offers
strategic and tactical support to clients for making well-informed business
decisions and to identify and achieve high-value opportunities in the target
business area. We also help our clients to address business challenges and
provide the best possible solutions to overcome them and transform their
business.
To know more
Contact Us:
Sales
Prophecy Market Insights
Email- sales@prophecymarketinsights.com
Website- www.prophecymarketinsights.com

Comments
Post a Comment